{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:57:36Z","timestamp":1772524656554,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41433-025-04190-6","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:26:06Z","timestamp":1766827566000},"page":"473-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three-year outcomes of polypoidal choroidal vasculopathy according to polypoidal regression on optical coherence tomography angiography"],"prefix":"10.1038","volume":"40","author":[{"given":"Jaehwan","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eung Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-5178","authenticated-orcid":false,"given":"Seung-Young","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"4190_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/ceo.13114","volume":"46","author":"KK Dansingani","year":"2018","unstructured":"Dansingani KK, Gal-Or O, Sadda SR, Yannuzzi LA, Freund KB. Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of \u2018expanded spectra\u2019 - a review. Clin Exp Ophthalmol. 2018;46:189\u2013200.","journal-title":"Clin Exp Ophthalmol"},{"key":"4190_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","volume":"15","author":"RF Spaide","year":"1995","unstructured":"Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina. 1995;15:100\u201310.","journal-title":"Retina"},{"key":"4190_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990;10:1\u20138.","journal-title":"Retina"},{"key":"4190_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajo.2014.05.004","volume":"158","author":"G Coscas","year":"2014","unstructured":"Coscas G, Yamashiro K, Coscas F, De Benedetto U, Tsujikawa A, Miyake M, et al. Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging. Am J Ophthalmol. 2014;158:309\u201318.e2.","journal-title":"Am J Ophthalmol"},{"key":"4190_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2009.10.001","volume":"29","author":"A Laude","year":"2010","unstructured":"Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res. 2010;29:19\u201329.","journal-title":"Prog Retin Eye Res"},{"key":"4190_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","volume":"144","author":"I Maruko","year":"2007","unstructured":"Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15\u201322.","journal-title":"Am J Ophthalmol"},{"key":"4190_CR7","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1097\/IAE.0000000000003595","volume":"42","author":"CS Tan","year":"2022","unstructured":"Tan CS, Gemmy Cheung CM, Lai TYY, Pataluskaite R, Margaron P, Lim TH. Predictors and importance of complete polypoidal lesion regression in the EVEREST II study: predictors of polyp regression in polypoidal choroidal vasculopathy. Retina. 2022;42:2091\u20138.","journal-title":"Retina"},{"key":"4190_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1136\/bjophthalmol-2016-310074","volume":"101","author":"S Yadav","year":"2017","unstructured":"Yadav S, Parry DG, Beare NAV, Pearce IA. Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians. Br J Ophthalmol. 2017;101:1377\u201380.","journal-title":"Br J Ophthalmol"},{"key":"4190_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamaophthalmol.2019.0449","volume":"137","author":"Q Bo","year":"2019","unstructured":"Bo Q, Yan Q, Shen M, Song M, Sun M, Yu Y, et al. Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography. JAMA Ophthalmol. 2019;137:642\u201350.","journal-title":"JAMA Ophthalmol"},{"key":"4190_CR10","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00417-015-2933-2","volume":"253","author":"CM Cheung","year":"2015","unstructured":"Cheung CM, Yang E, Lee WK, Lee GK, Mathur R, Cheng J, et al. The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients. Graefes Arch Clin Exp Ophthalmol. 2015;253:2075\u201385.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4190_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"A Koh","year":"2012","unstructured":"Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, et al. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina. 2012;32:1453\u201364.","journal-title":"Retina"},{"key":"4190_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0002-9394(02)01404-6","volume":"133","author":"M Uyama","year":"2002","unstructured":"Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol. 2002;133:639\u201348.","journal-title":"Am J Ophthalmol"},{"key":"4190_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ophtha.2022.09.013","volume":"130","author":"Q Bo","year":"2023","unstructured":"Bo Q, Zhang M, Chen J, Jia H, Shen M, Sun M, et al. Progression of polypoidal lesions associated with exudative recurrence in polypoidal choroidal vasculopathy. Ophthalmology. 2023;130:167\u201378.","journal-title":"Ophthalmology"},{"key":"4190_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","volume":"33","author":"AH Koh","year":"2013","unstructured":"Koh AH, Chen LJ, Chen SJ, Chen Y, Giridhar A, Iida T, et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina. 2013;33:686\u2013716.","journal-title":"Retina"},{"key":"4190_CR15","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, et al. Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology. 2018;125:708\u201324.","journal-title":"Ophthalmology"},{"key":"4190_CR16","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1097\/IAE.0000000000002760","volume":"40","author":"A Fujita","year":"2020","unstructured":"Fujita A, Kataoka K, Takeuchi J, Nakano Y, Horiguchi E, Kaneko H, et al. Diagnostic characteristics of polypoidal choroidal vasculopathy based on B-scan swept-source optical coherence tomography angiography and its interrater agreement compared with indocyanine green angiography. Retina. 2020;40:2296\u2013303.","journal-title":"Retina"},{"key":"4190_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","volume":"128","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen SJ, Kim JE, et al. Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup. Ophthalmology. 2021;128:443\u201352.","journal-title":"Ophthalmology"},{"key":"4190_CR18","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ajo.2014.08.025","volume":"158","author":"G De Salvo","year":"2014","unstructured":"De Salvo G, Vaz-Pereira S, Keane PA, Tufail A, Liew G. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol. 2014;158:1228\u201338.e1.","journal-title":"Am J Ophthalmol"},{"key":"4190_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamaophthalmol.2019.0565","volume":"137","author":"V Chaikitmongkol","year":"2019","unstructured":"Chaikitmongkol V, Kong J, Khunsongkiet P, Patikulsila D, Sachdeva M, Chavengsaksongkram P, et al. Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol. 2019;137:661\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"4190_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ajo.2020.05.017","volume":"217","author":"K Kim","year":"2020","unstructured":"Kim K, Yang J, Feuer W, Gregori G, Kim ES, Rosenfeld PJ, et al. A comparison study of polypoidal choroidal vasculopathy imaged with indocyanine green angiography and swept-source optical coherence tomography angiography. Am J Ophthalmol. 2020;217:240\u201351.","journal-title":"Am J Ophthalmol"},{"key":"4190_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.oret.2021.03.012","volume":"6","author":"V Chaikitmongkol","year":"2022","unstructured":"Chaikitmongkol V, Upaphong P, Patikulsila D, Jirarattanasopa P, Choovuthayakorn J, Watanachai N, et al. Timing of complete polypoidal regression after intravitreous aflibercept treatments in polypoidal choroidal vasculopathy. Ophthalmol Retin. 2022;6:21\u20138.","journal-title":"Ophthalmol Retin"},{"key":"4190_CR22","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/eye.2014.222","volume":"28","author":"M Ho","year":"2014","unstructured":"Ho M, Lo EC, Young AL, Liu DT. Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome. Eye (Lond). 2014;28:1469\u201376.","journal-title":"Eye (Lond)"},{"key":"4190_CR23","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/bjophthalmol-2014-305275","volume":"99","author":"M Hosokawa","year":"2015","unstructured":"Hosokawa M, Shiraga F, Yamashita A, Shiragami C, Ono A, Shirakata Y, et al. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy. Br J Ophthalmol. 2015;99:1087\u201391.","journal-title":"Br J Ophthalmol"},{"key":"4190_CR24","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1097\/IAE.0000000000000229","volume":"34","author":"M Inoue","year":"2014","unstructured":"Inoue M, Arakawa A, Yamane S, Kadonosono K. Short-term efficacy of intravitreal aflibercept in treatment-naive patients with polypoidal choroidal vasculopathy. Retina. 2014;34:2178\u201384.","journal-title":"Retina"},{"key":"4190_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00417-016-3489-5","volume":"255","author":"JE Lee","year":"2017","unstructured":"Lee JE, Shin JP, Kim HW, Chang W, Kim YC, Lee SJ, et al. Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study. Graefes Arch Clin Exp Ophthalmol. 2017;255:493\u2013502.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4190_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000477448","volume":"238","author":"Y Oshima","year":"2017","unstructured":"Oshima Y, Kimoto K, Yoshida N, Fujisawa K, Sonoda S, Kubota T, et al. One-year outcomes following intravitreal aflibercept for polypoidal choroidal vasculopathy in Japanese patients: the APOLLO study. Ophthalmologica. 2017;238:163\u201371.","journal-title":"Ophthalmologica"},{"key":"4190_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000488808","volume":"240","author":"B Wolff","year":"2018","unstructured":"Wolff B, Vasseur V, Cahuzac A, Coscas F, Castelnovo L, Favard C, et al. Aflibercept treatment in polypoidal choroidal vasculopathy: results of a prospective study in a caucasian population. Ophthalmologica. 2018;240:208\u201312.","journal-title":"Ophthalmologica"},{"key":"4190_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2019.02.027","volume":"204","author":"TY Wong","year":"2019","unstructured":"Wong TY, Ogura Y, Lee WK, Iida T, Chen SJ, Mitchell P, et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the aflibercept in polypoidal choroidal vasculopathy study. Am J Ophthalmol. 2019;204:80\u20139.","journal-title":"Am J Ophthalmol"},{"key":"4190_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.oret.2023.11.001","volume":"8","author":"KYC Teo","year":"2024","unstructured":"Teo KYC, Zhao JZ, Klose G, Lee WK, Cheung CMG. Polypoidal choroidal vasculopathy: evaluation based on 3-dimensional reconstruction of OCT angiography. Ophthalmol Retin. 2024;8:98\u2013107.","journal-title":"Ophthalmol Retin"},{"key":"4190_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51628-0","volume":"14","author":"J Hoshino","year":"2024","unstructured":"Hoshino J, Matsumoto H, Nakamura K, Akiyama H. Predicting treatment outcomes of intravitreal brolucizumab for polypoidal choroidal vasculopathy through noninvasive assessment of polypoidal lesion blood flow with optical coherence tomography angiography. Sci Rep. 2024;14:961.","journal-title":"Sci Rep"},{"key":"4190_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.62.15.5","volume":"62","author":"M Shen","year":"2021","unstructured":"Shen M, Zhou H, Kim K, Bo Q, Lu J, Laiginhas R, et al. Choroidal Changes in Eyes With Polypoidal Choroidal Vasculopathy After Anti-VEGF Therapy Imaged With Swept-Source OCT Angiography. Invest Ophthalmol Vis Sci. 2021;62:5.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4190_CR32","doi-asserted-by":"publisher","DOI":"10.1590\/1677-5449.200211","volume":"20","author":"VP Dos Santos","year":"2021","unstructured":"Dos Santos VP, Pozzan G, Castelli V, Caffaro RA. Arteriosclerosis, atherosclerosis, arteriolosclerosis, and Monckeberg medial calcific sclerosis: what is the difference? J Vasc Bras. 2021;20:e20200211.","journal-title":"J Vasc Bras"},{"key":"4190_CR33","doi-asserted-by":"crossref","unstructured":"Jebari-Benslaiman S, Galicia-Garc\u00eda U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022;23:3346.","DOI":"10.3390\/ijms23063346"},{"key":"4190_CR34","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/bjo.86.10.1093","volume":"86","author":"A Okubo","year":"2002","unstructured":"Okubo A, Sameshima M, Uemura A, Kanda S, Ohba N. Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol. 2002;86:1093\u20138.","journal-title":"Br J Ophthalmol"},{"key":"4190_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/bjo.86.3.321","volume":"86","author":"H Terasaki","year":"2002","unstructured":"Terasaki H, Miyake Y, Suzuki T, Nakamura M, Nagasaka T. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol. 2002;86:321\u20137.","journal-title":"Br J Ophthalmol"},{"key":"4190_CR36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1442-9071.2004.00827.x","volume":"32","author":"S Kuroiwa","year":"2004","unstructured":"Kuroiwa S, Tateiwa H, Hisatomi T, Ishibashi T, Yoshimura N. Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Exp Ophthalmol. 2004;32:297\u2013302.","journal-title":"Clin Exp Ophthalmol"},{"key":"4190_CR37","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1167\/iovs.08-2134","volume":"49","author":"H Nakashizuka","year":"2008","unstructured":"Nakashizuka H, Mitsumata M, Okisaka S, Shimada H, Kawamura A, Mori R, et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2008;49:4729\u201337.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04190-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04190-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04190-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:12:51Z","timestamp":1772521971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04190-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4190"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04190-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Kyung Hee University Hospital (2024-10-001). The requirement for written informed consent was waived by the Institutional Review Board of Kyung Hee University Hospital owing to the retrospective nature of the study. This study was conducted in accordance with the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}